Clinical Research of Diquas ophthalmic solution 3% on corneal epithelial barrier function in dry eye

Clinical Research of Diquas ophthalmic solution 3% on corneal epithelial barrier function in dry eye - Clinical Research of Corneal epithelial barrier function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021884

Enrollment

Registered

2016-04-12

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Diquafosol sodium ophthalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as definite and probable dry eye, and corneal and conjunctival staining 1 point and over [9 point scale].

Exclusion criteria

Exclusion criteria: Patients with a history of allergy to fluorescein Patients who have allergic conjunctivitis, and have possibilities to get worse during study phase. Experience in using Diquas ophthalmic solution 3%. The investigator or subinvestigator has judged that the patient is ineligible as study subject.

Design outcomes

Primary

Measure	Time frame
Corneal epithelial barrier function	—

Countries

Japan

Contacts

Public ContactMasakazu Yamada

Kyorin university School of Medicine Department of ophthalmology

yamada@eye-center.org0422-47-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026